Details for Patent: 5,474,535
✉ Email this page to a colleague
Summary for Patent: 5,474,535
Title: | Dosage and inserter for treatment of erectile dysfunction |
Abstract: | Erectile dysfunction, particularly impotence, priapism and Peyronie's disease is treated by the transurethral administration of a therapeutically effective agent. The agents are administered to the urethra by means of a penile insert (40) having a shaft with a deformable distal end which forms a dose receiving cavity when an internal piston is retracted relative to the shaft. |
Inventor(s): | Place; Virgil A. (Kawaihae, HI), Gale; Robert M. (Los Altos, CA), Berggren; Randall G. (Livermore, CA) |
Assignee: | Vivus, Inc. (Menlo Park, CA) |
Application Number: | 08/093,545 |
Patent Claim Types: see list of patent claims | Use; Dosage form; Composition; |
Drugs Protected by US Patent 5,474,535
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,474,535
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 173603 | ⤷ Sign Up | |||
Australia | 655420 | ⤷ Sign Up | |||
Australia | 7856391 | ⤷ Sign Up | |||
Canada | 2040914 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |